Medtech stocks rebounded from a significant dip earlier in June last week, continuing to highlight the topsy-turvy nature of the markets during the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 85.00 points at the end of last week (June 19). That total represents […]
Former Merit Medical executive claims physician kickbacks in whistleblower lawsuit
The U.S. has joined in a whistleblower lawsuit filed by the former chief compliance officer of Merit Medical (NSDQ:MMSI), who claims the company ran a fraud scheme involving physician kickbacks. Dr. Charles Wolf alleges the Salt Lake City-based medical device company engaged in unlawful kickbacks to induce physicians to use more of its Embosphere and QuadraSphere […]
Merit Medical lands CE mark for Wrapsody endovascular stent graft
Merit Medical (NSDQ:MMSI) announced that it received CE Mark approval in Europe for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis indicated for use in hemodialysis patients for treating stenosis or occlusion within central veins, along with the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft, according to a […]
Merit Medical wins FDA breakthrough nods
Merit Medical (NSDQ:MMSI) systems announced that it won two additional breakthrough device designations from the FDA for its Wrapsody endovascular stent graft system. Wrapsody is designed as a flexible, self-expanding endoprosthesis and won a breakthrough nod in November 2019 for hemodialysis treatment. Its latest indications include treating stenosis or occlusion within the dialysis outflow circuit, including […]
Merit Medical lands breakthrough designation for dialysis stent graft system
Merit Medical (NSDQ:MMSI) announced last week that it has been granted FDA breakthrough device designation for its Wrapsody endovascular stent graft system. Wrapsody is a flexible, self-expanding endoprosthesis designed for hemodialysis patients. Merit said it will seek indication to treat stenosis within the central veins of the outflow circuit of an arteriovenous fistula (AVF) up […]
Merit Medical closes $50m BrightWater buyout
BrightWater Medical said today that it completed the sale of the organization to Merit Medical (NSDQ:MMSI), three months after Merit made its $50 million offer. In June, Merit valued the acquisition at $35 million upfront with a further $15 million in potential payments contingent upon CE Mark approval and meeting future sales targets. Temecula, Calif.-based BrightWater’s […]
Merit Medical plunges on Q2 miss, lowered outlook
Merit Medical (NSDQ:MMSI) shares lost more than a quarter of their value today after the medical device maker missed the consensus for its second-quarter sales and earnings and lowered its outlook on the rest of the year. South Jordan, Utah-based Merit posted profits of $6.9 million, or 12¢ per share, on sales of $255.5 million for […]
Merit puts $50m on the table for Brightwater
Merit Medical (NSDQ:MMSI) said this week that it plans to acquire Brightwater Medical in a deal valued at $50 million. Temecula, Calif.-based Brightwater Medical’s lead product, ConvertX, is a device designed to treat severe obstructions of the ureter. The company recently won FDA clearance for its ConvertX biliary stent system, according to Merit Medical. The deal […]
Merit Medical’s Q1 beats push shares higher
A first-quarter sales-and-earnings beat pushed Merit Medical (NSDQ:MMSI) shares up today before the market opened, as the medical device maker maintained its outlook for 2019. South Jordan, Utah-based Merit reported profits of $6.2 million, or 11¢ per share, on sales of $238.3 million for the three months ended March 31, for a 10.0% profit gain on […]
Merit Medical’s Q4, 2018 top The Street
Merit Medical (NSDQ:MMSI) yesterday posted fourth-quarter and full-year sales and earnings that beat the consensus forecast on Wall Street. The South Jordan, Utah-based medical device company reported profits of $9.2 million, or 16¢ per share, on sales of $233.2 million for the three months ended Dec. 31, 2018, representing bottom-line growth of 35.0% on sales growth […]
Merit Medical puts $60m on the table for Vascular Insights
UPDATED May 1, 2019, with milestone terms. Merit Medical (NSDQ:MMSI) said yesterday that it put $60 million on the table to acquire Vascular Insights and its ClariVein line of catheters, including a $20 million milestone pegged to sales targets. Quincy, Mass.-based Vascular Insights makes the ClariVeinIC and ClariVeinOC infusion and occlusion catheters for treating superficial […]
- 1
- 2
- 3
- …
- 7
- Next Page »
